The Alkaline Water Company Inc. Announces Submission of its Application to List on NASDAQ and Closing of Private Placement
October 1, 2018
Ryan Allway October 1st, 2018 News, Top News SCOTTSDALE, Ariz., Oct. 01, 2018 (GLOBE NEWSWIRE) — The Alkaline Water Company Inc. (TSXV: WTER; OTCQB: WTER) (the “Company”) is pleased to announce that the Company has submitted its application to list its common shares on the NASDAQ Capital Market (“NASDAQ”). By up-listing to... Read more
The Green Organic Dutchman Announces C$75 Million Bought Deal
October 1, 2018
Ryan Allway October 1st, 2018 News, Top News TORONTO, Oct. 1, 2018 /CNW/ – The Green Organic Dutchman Holdings Ltd. (the “Company” or “TGOD”) (TSX:TGOD) (US:TGODF) is pleased to announce that it has entered into an agreement with a syndicate of underwriters led by Canaccord Genuity Corp. (the “Underwriters”)... Read more
Ryan Allway September 28th, 2018 News, Top News Kelowna, British Columbia / TheNewswire / September 28, 2018 – Lexaria Bioscience Corp. (OTCQX: LXRP) (CSE: LXX) (the “Company” or “Lexaria”), a drug delivery platform innovator, announces the filing of a new strategic patent application. The new provisional patent application is entitled... Read more
GW Pharmaceuticals plc and its U.S. Subsidiary Greenwich Biosciences Announce the DEA has Rescheduled EPIDIOLEX® (cannabidiol) Oral Solution to Schedule V
September 27, 2018
Ryan Allway September 27th, 2018 News, Top News LONDON and CARLSBAD, Calif., Sept. 27, 2018 (GLOBE NEWSWIRE) — GW Pharmaceuticals plc (Nasdaq: GWPH, “GW,” “the Company” or “the Group”), a biopharmaceutical company focused on discovering, developing and commercializing novel therapeutics from its proprietary cannabinoid product platform, along with... Read more
MedMen Enterprises Inc. Announces Closing of Its C$86 Million Bought Deal Financing
September 27, 2018
Ryan Allway September 27th, 2018 News, Top News LOS ANGELES, Sept. 27, 2018 (GLOBE NEWSWIRE) — MedMen Enterprises Inc. (“MedMen” or the “Company”) (CSE: MMEN) (OTCQB: MMNFF) (FSE: A2JM6N) is pleased to announce that it has completed its previously-announced bought deal financing (the “Offering”) of 15,681,818 units (the “Units”) at... Read more
Pure Global Completes Initial Sales License Review and Launches Groundbreaking Medical Cannabis Research Study with Appletree Medical Group
September 27, 2018
TORONTO, Sept. 27, 2018 /CNW/ – Pure Global Cannabis Inc. (TSX.V:PURE; OTC: PRCNF; FRA:1QS) (the “Company” or “Pure Global” or “PURE“) is pleased to announce that its wholly-owned subsidiary, PureSinse Inc. (“PureSinse“), has completed its initial Sales License review with Health Canada (“Sales License”) and has entered into a multi-year agreement... Read more
FSD Pharma Added to Leading Cannabis ETF With Significant 1.9% Weighting
September 27, 2018
Ryan Allway September 27th, 2018 News, Top News TORONTO, Sept. 27, 2018 /CNW/ – FSD Pharma Inc. (“FSD Pharma” or the “Company”) (CSE: HUGE) (OTCQB: FSDDF) (FRA: 0K9) is pleased to announce that Horizons ETFs Management (Canada) Inc. (“Horizons ETFs”) has added the Company to the Horizons Marijuana Life Sciences Index ETF (“HMMJ:TSX“)... Read more
AREV Shifts into High Gear
September 25, 2018
Ryan Allway September 25th, 2018 Feature Stories, News, Top News AREV Brands International (CSE: AREV) is a cannabis integrator that has parlayed its history with natural health products into an intriguing and streamlined cannabis company. Through a series of accretive acquisitions, the company has transformed into a Canadian-based... Read more
Abattis Unveils “Comfort”, Its Proprietary New Chronic Pain and Inflammation Product to Start Shipping November 2018
September 24, 2018
VANCOUVER, British Columbia, Sept. 24, 2018 (GLOBE NEWSWIRE) — Abattis Bioceuticals Corp. (the “Company” or “Abattis”) (CSE:ATT) (OTC:ATTBF) is pleased to announce the pending release of “Comfort”, a nutraceutical designed to target chronic pain and inflammation. As previously announced, the Company hopes to launch Comfort on Cyber Monday through the Company’s... Read more
CWCBExpo Offers Networking & Insights to Cannabis Investors & Executives
September 24, 2018
Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. Emerging Growth LLC dba TDM Financial, which owns CannabisFN, is not... Read more
